glp-1 secretion mechanism GLP-1: Actions on Beta-cell Mass
Description
It has 2 new drug applications under regulatory review, 4 assets in Phase 3 or pivotal clinical trials and 15 more molecules in early clinical stage
doi: 10.3390/ijms20081940 77 BaiFZhangLHZhangWWZhengRHEskewJRBennettJet al
Best Practices for GLP-1 Injection Placement The four common subcutaneous injection sites are the abdomen, thighs, back of the upper arms, and upper buttocks
Outcomes were tracked over a two-year follow-up period
doi: 10.1007/s11154-014-9289-5 [DOI] [PMC free article] [PubMed] [Google Scholar] 21.Nauck MA, Niedereichholz U, Ettler R, et al
